Skip to main content
. 2019 Apr 5;7:55. doi: 10.3389/fped.2019.00055

Table 1.

Clinical history and immune phenotyping of patients A and B, and additional studies on family members.

Patient A (<1 mo) Patient B (9 mo) Reference range
Clinical presentation at time of lab evaluation asymptomatic PJP pneumonia on steroids
Phenotype of SCID variant T/B+/NKlow T+(CD8low)/B+/NKlow
TREC (copies/microliter) at birth* 0 (L*) 0 (L*) >15 [Patient A NBS in Florida],
> 252 [Patient B NBS Massachusetts]
Absolute lymphocyte (cells/μL) 669 (L) 1,596 (L) >2,600
Absolute CD3 T (cells/μL) 9 (L) 1,062 (L) >1,600
Absolute CD4 T (cells/μL) 9 (L) 1,043 >1,000
Absolute CD8 T (cells/μL) 7 (L) 27 (L) >400
Absolute CD19 B (cells/μL) 450 (L) 365 (L) >600
Absolute CD56 NK (cells/μL) 61 (L) 145 (L) >200
CD4+CD45RA+ naïve T (cells/μL), (% of total CD4) 1 (11%) (L) 0 (L) >50% of total CD4
CD8+CD45RA+ naïve T (cells/μL), (% of total CD8) 2 (30%) (L) 0 (L) >50% of total CD8
CD3+ T cell proliferation to mitogens PHA 0.9% (L) 7.1% (L) >58.4%
PWM 11.5% 4.1% >3.4%
T cell proliferation with interleukins anti-CD3
anti-CD3/CD28 n.a. Absent
anti-CD3/IL-2
CD132 (common γ chain) expression T cells n.a. 84% (L) >99%
B cells 87% 84% >58%
NK cells 71% (L) 66% (L) >84%
CD132 signaling absent absent
X chromosome inactivation (XCI) in carriers
Mother PBMC 76:24 85:15 (H) <80:20
Mother T cells 100:0 (H) 100:0 (H) <80:20
13-year-old sister PBMC 90:10 (H) n.a. <80:20
14-year-old sister PBMC 91:9 (H) n.a. <80:20

X-inactivation studies on peripheral blood mononuclear cells (PBMCs) were performed by Greenwood Genetics (Greenwood, SC). This study does not allow for distinguishing wild type (wt) or mutant alleles. X-inactivation studies in T cells at the NIH allowed for distinction between wt and mutant alleles (Figure 2A). *From NBS card. L indicates low, H indicates high. PJP: Pneumocystis jirovecii pneumonia.